Home > Insider Trading > Filing (0000899243-20-019894)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1807901	Pandion Therapeutics Inc.	PAND	()	1231

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1015747	Joseph Lewis	Cay House, Ep Taylor Drive N7776 Lyford Cay New Providence C5	No	No	Yes	No
1465836	Boxer Asset Management Inc.	Cay House, Ep Taylor Drive N7776 Lyford Cay New Providence C5	No	No	Yes	No
1465837	Boxer Capital, Llc	11682 El Camino Real, Suite 320 San Diego CA 92130	No	No	Yes	No
1465914	I. Aaron Davis	11682 El Camino Real, Suite 320 San Diego CA 92130	No	No	Yes	No
1468223	Mva Investors, Llc	11682 El Camino Real, Suite 320 San Diego CA 92130	No	No	Yes	No
1642355	Ltd. Braslyn	Cay House, Ep Taylor Drive N7776 Lyford Cay New Providence C5	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-21	1,385,291	$0.00	1,385,291	No	4	C	Direct
Common Stock	Acquisiton	2020-07-21	23,622	$0.00	23,622	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-21	722,222	$18.00	2,107,513	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Indirect	See footnote
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2020-07-21	7,064,136	$0.00	1,385,291	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-07-21	120,460	$0.00	23,622	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Indirect

Footnotes

The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Braslyn Ltd. ("Braslyn"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC ("MVA Investors") and (vi) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.